February 18, 2022
Media coverage in 2020 surrounded a particular virus and the progress made in defeating it. Similarly, new treatments, drug regimens, and cutting-edge and highly successful trials gave a glimmer of hope to those suffering from mesothelioma, not to mention their family members. Some of the more prominent stories included: The FDA approves Keytruda Pembrolizumab, an [...]